CAPTRUST Financial Advisors’s Safeguard Scientifics, Inc. SFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,933
Closed -$11K 4351
2022
Q2
$11K Buy
2,933
+2,433
+487% +$10.2K ﹤0.01% 3716
2022
Q1
$3K Sell
500
-2,933
-85% -$17.8K ﹤0.01% 4415
2021
Q4
$25K Sell
3,433
-377
-10% -$2.94K ﹤0.01% 3154
2021
Q3
$34K Sell
3,810
-151
-4% -$1.21K ﹤0.01% 2831
2021
Q2
$31K Sell
3,961
-99
-2% -$675 ﹤0.01% 2827
2021
Q1
$28K Buy
4,060
+627
+18% +$4.55K ﹤0.01% 2799
2020
Q4
$22K Buy
3,433
+2,858
+497% +$17.8K ﹤0.01% 2210
2020
Q3
$3K Sell
575
-2,933
-84% -$17.5K ﹤0.01% 2695
2020
Q2
$24K Buy
+3,508
New +$22.2K ﹤0.01% 1875
2019
Q4
Sell
-3,008
Closed -$34K 1897
2019
Q3
$34K Hold
3,008
﹤0.01% 1128
2019
Q2
$36K Buy
3,008
+2,200
+272% +$25.8K ﹤0.01% 1101
2019
Q1
$9K Buy
808
+733
+977% +$7.43K ﹤0.01% 1425
2018
Q4
$1K Hold
75
﹤0.01% 1561
2018
Q3
$1K Hold
75
﹤0.01% 1532
2018
Q2
$1K Buy
+75
New +$968 ﹤0.01% 1480

Other funds holding SFE

CAPTRUST Financial Advisors's SFE Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Safeguard Scientifics, Inc. (SFE) in Q3 2022, closing a stake of 2,933 shares — an estimated $11K sold.

CAPTRUST Financial Advisors first reported a position in SFE in Q2 2018 and held it in 15 quarters. The position peaked at $36K in Q2 2019. 47 funds tracked by Wall St. Rank hold SFE as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Safeguard Scientifics, Inc. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,933 Safeguard Scientifics, Inc. shares in Q3 2022, an estimated $11K.
  • CAPTRUST Financial Advisors first reported a position in Safeguard Scientifics, Inc. in Q2 2018 and held it in 15 quarters.
  • CAPTRUST Financial Advisors's Safeguard Scientifics, Inc. position peaked at $36K in Q2 2019.
  • 47 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.